Get the Stockscreener App
88.18
0.20%
0.18
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $88.18, with a volume of 2.81M.
It is up +0.20% in the last 24 hours and up +10.09% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$88.00
Open:
$88.65
24h Volume:
2.81M
Relative Volume:
0.74
Market Cap:
$42.87B
Revenue:
$6.13B
Net Income/Loss:
$272.21M
P/E Ratio:
159.72
EPS:
0.5521
Net Cash Flow:
$1.38B
1W Performance:
+0.83%
1M Performance:
+10.09%
6M Performance:
+11.28%
1Y Performance:
+38.54%
1-Day Range:
$87.90
$89.27
1-Week Range:
$87.09
$89.84
52-Week Range:
$61.76
$91.06
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, CTRE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
88.18 | 42.78B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
216.17 | 152.48B | 11.75B | 1.46B | 2.19B | -0.6014 |
OHI
Omega Healthcare Investors Inc
|
47.90 | 14.37B | 1.24B | 655.98M | 857.80M | 2.063 |
DOC
Healthpeak Properties Inc
|
19.73 | 13.54B | 2.87B | 250.10M | 1.13B | 0.3188 |
CTRE
Caretrust Reit Inc
|
41.14 | 9.69B | 522.75M | 333.94M | 397.14M | 1.5617 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Goldman | Buy |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Diamond Hill Capital Management Inc. Sells 12,199 Shares of Ventas, Inc. $VTR - MarketBeat
Mizuho raises Ventas stock price target to $98 on higher estimates - Investing.com Canada
Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating - marketscreener.com
Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating - marketscreener.com
VTR Price Today: Ventas, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Ventas Inc. stock (US92276F1003): ATM expansion and SHOP growth keep healthcare REIT in focus - AD HOC NEWS
Ventas Is Maintained at Sector Perform by Scotiabank - Moomoo
Ventas stock (US9182041080): Scotiabank raises target to $95 - AD HOC NEWS
Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating - marketscreener.com
Ventas, Inc. $VTR Shares Sold by Handelsbanken Fonder AB - MarketBeat
Ventas Inc. Earnings Call Signals Strong SHOP Surge - TipRanks
Aew Capital Management L P Sells 87,710 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock (US92276F1003): ATM expansion puts capital flexibility in focus - AD HOC NEWS
Ventas’s SWOT analysis: healthcare REIT stock faces demographic tailwinds - Investing.com India
Ventas Expands ATM Program to Bolster Capital Flexibility - TipRanks
Ventas stock (US92276F1003): Healthcare REIT outlines growth strategy after recent quarterly results - AD HOC NEWS
North Dakota State Investment Board Purchases New Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas’s SWOT analysis: healthcare REIT stock faces demographic tailwinds By Investing.com - Investing.com South Africa
Ventas stock (US92276F1003): healthcare REIT in focus after latest quarterly results - AD HOC NEWS
News | Global healthcare REIT closes on senior housing facility in Boulder - CoStar
Goldman Sachs Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $110 - 富途牛牛
Goldman Sachs Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating - marketscreener.com
Ventas stock (US92276F1003): Q1 results highlight senior housing growth - AD HOC NEWS
Ventas stock (US92276F1003): healthcare REIT updates investors after latest quarterly results - AD HOC NEWS
AlphaCore Capital LLC Invests $1.26 Million in Ventas, Inc. $VTR - MarketBeat
Here is Why Ventas (VTR) is One of the Best Large Cap Stocks to Buy Under $100 - Insider Monkey
Ventas Expands Equity Program And Confirms Governance Stability Might Change The Case For Investing In Ventas (VTR) - simplywall.st
Ventas Inc. stock (US92276F1003): Latest company update and what investors are watching - AD HOC NEWS
Ventyx Biosciences stock (US92276F1003): clinical setbacks keep investors on edge - AD HOC NEWS
(VTR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ANTIPODES PARTNERS Ltd Sells 243,423 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas to buy 85 per cent of Le Groupe Maurice for $2B - RENX
Ventas, Inc. Announces SEC Filing and Dealer Agreements for Common Stock (VTR) on NYSE - Minichart
Ventas updates ATM sales agreement and announces annual meeting results By Investing.com - Investing.com Australia
Ventas director Rakowich sells $103,915 in company stock - Investing.com UK
Ventas updates ATM sales agreement and announces annual meeting results - Investing.com
Ventas director Rakowich sells $103,915 in company stock By Investing.com - Investing.com Australia
Insider Selling: Ventas (NYSE:VTR) Director Sells 1,152 Shares of Stock - MarketBeat
Ventas's Peter J. Bulgarelli to Receive Prorated 2026 Bonus upon Retirement - TradingView
Ventas (NYSE: VTR) updates ATM program — up to $3.0B common stock available - Stock Titan
Ventas (VTR) director awarded 2,047 restricted stock units under 2022 plan - Stock Titan
Ventas (VTR) boosts $3B ATM equity capacity and confirms 2026 vote results - Stock Titan
Ventas IncEnters amendment no. 3 to ATM sales agreement on May 15, 2026SEC filing - marketscreener.com
Ventas, Inc. (NYSE: VTR) director receives 2,047-share stock award - Stock Titan
Director Sumit Roy receives 2,047-share equity award at Ventas (NYSE: VTR) - Stock Titan
Ventas (NYSE: VTR) director sells 1,152 shares, receives 2,047 RSUs - Stock Titan
Ventas (VTR) director Sean P. Nolan receives 2,047 restricted stock units grant - Stock Titan
Ventas (VTR) director Marguerite Nader awarded 2,047 restricted stock units - Stock Titan
Ventas (VTR) director Roxanne Martino receives 2,047 restricted stock units grant - Stock Titan
Ventas (VTR) director Matthew Lustig receives 2,047 restricted stock units grant - Stock Titan
Ventas (VTR) director receives 2,047 RSUs under 2022 incentive plan - Stock Titan
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.75%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):